Barclays Maintains an 'Underweight' on Cephalon (CEPH); Valeant Offer Provides Exit from Core Risk
Tweet Send to a Friend
Barclays maintains an 'Underweight' on Cephalon (NASDAQ: CEPH), raises PT from $45 to $73.
Barclays analyst says, "We are maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "We are maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
